Arthritis

Please Note: The technologies listed here are not available to the public at this time. These technologies are in the early stages of research and require further development before they are ready for the marketplace. The VA is currently in the process of identifying potential companies who may be interested in licensing and/or further developing the technology through Cooperative Research and Development Agreements (CRADA). Through cooperative research initiatives such as these, it is our hope and goal that commercial products will be fully developed and made available to benefit veterans and others.

Navigate This Topic:

Arthritis


Date Posted

Reference No.

Patent No.

Title

07/07/2004

02-124

Isolation and Characterization of Human Marrow-Isolated Adult Multipotent Inducible (MIAMI) Cells

03/22/2002

00-045

6,908,899

Pro-inflammatory Fibrinopeptide

04/12/2002

00-033

Neu Differentiation Factor-Beta (NFD-ß), a Potent Inhibitor of Angiogenesis and a Schwann-Cell Derived Factor Capable of Inducing Differentiation in Human Neuroblastoma Tumor Cells